Baxalta Incorporated Common Sto (BXLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BXLT | INSM | BIIB | ||
| Company | Baxalta Incorporated Common Sto | Insmed Inc | Biogen Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 46.27 | 195.00 | 173.49 | ||
| High | 46.52 | 198.13 | 175.08 | ||
| Low | 46.01 | 191.74 | 171.27 | ||
| Latest | 46.02 | 197.01 | 174.10 | ||
| Change | -0.18 | +1.77 | +1.60 | ||
| % Change | -0.39% | +0.91% | +0.93% | ||
| Volume | 228,648,297 | 1,898,000 | 1,781,400 | ||
| 20-Day Average Volume | 24,994,385 | 2,836,440 | 1,968,845 | ||
| Previous Close | 46.20 | 195.24 | 172.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 43.79 | 201.45 | 175.88 | ||
| 20-Day Raw Stochastic | 91.45% | 37.54% | 50.07% | ||
| 20-Day Relative Strength | 68.35 | 56.00 | 58.03 | ||
| Weighted Alpha | +50.40 | +172.11 | +27.89 | ||
| Today's Opinion | N/A | 80% Buy | 88% Buy | ||
| Previous Opinion | N/A | 80% Buy | 88% Buy | ||
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.70% since 05/26/16 | -3.43% since 12/05/25 | -3.97% since 12/05/25 | ||
| Low | 45.23 on 05/31/16 | 189.59 on 12/10/25 | 169.24 on 12/10/25 | ||
| High | 46.52 on 06/02/16 | 206.69 on 12/08/25 | 182.12 on 12/08/25 | ||
| 1-Month | |||||
| %Chg | +9.21% since 05/02/16 | +1.35% since 11/12/25 | +7.82% since 11/12/25 | ||
| Low | 40.67 on 05/06/16 | 187.55 on 11/14/25 | 161.20 on 11/13/25 | ||
| High | 46.52 on 06/02/16 | 212.75 on 12/02/25 | 185.17 on 11/24/25 | ||
| 3-Month | |||||
| %Chg | +15.34% since 03/02/16 | +35.00% since 09/12/25 | +20.19% since 09/12/25 | ||
| Low | 37.44 on 03/16/16 | 134.01 on 09/26/25 | 135.39 on 09/29/25 | ||
| High | 46.52 on 06/02/16 | 212.75 on 12/02/25 | 185.17 on 11/24/25 | ||
| 6-Month | |||||
| %Chg | +29.16% since 12/02/15 | +103.35% since 06/12/25 | +31.58% since 06/12/25 | ||
| Low | 34.50 on 12/04/15 | 95.01 on 07/07/25 | 121.05 on 07/21/25 | ||
| High | 46.52 on 06/02/16 | 212.75 on 12/02/25 | 185.17 on 11/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,579,550 | 42,016,912 | 25,540,818 | ||
| Shares Outstanding, K | 683,080 | 213,273 | 146,702 | ||
| Annual Sales | 6,148,000,000 | 363,710,000 | 9,675,900,000 | ||
| Annual Net Income | 956,000,000 | -913,770,000 | 1,632,200,000 | ||
| Last Quarter Sales | 1,548,000,000 | 142,340,000 | 2,534,700,000 | ||
| Last Quarter Net Income | 145,000,000 | -370,020,000 | 466,500,000 | ||
| 60-Month Beta | N/A | 1.01 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.47 on 04/28/16 | -1.75 on 10/30/25 | 4.81 on 10/30/25 | ||
| Latest Earnings Date | 08/04/16 | 02/19/26 | 02/11/26 | ||
| Most Recent Dividend | 0.070 on 03/08/16 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/08/16 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.10 | 0.00 | 10.30 | ||